Kunshan Yiyuan Medical Technology Co., Ltd (Medical Source), a company in China that specializes in the development of disruptive CT tubes, has reportedly raised over RMB 100 million in a Series B financing round. The round was led by Everest Venture Capital, with participation from Gaotou Venture Capital and Riverhead Capital, the latter being a returning investor.
High-Value Consumables Market and Domestic Brand Presence
CT tubes are considered high-value consumables in the medical industry. In China, domestic brands currently hold a mere 5% share of the total market. This significant funding for Kunshan Yiyuan Medical Technology aims to bolster the company’s position in the market and potentially increase the presence of domestic brands in the CT tube sector.-Fineline Info & Tech
